Over the past 15 years, I have presented individual herbal therapeutics for testing in several research institutes to determine their effectiveness and also their safety which was indicated by toxicity data.
These included:
Influenza testing: Professor Enzo Palombo and Dr. Dhivya Raja Sekaran at Swinburne University
Rhinovirus testing: Professor Philip Bardiin and Dr. Belinda Thomas at Melbourne institute of medical research-phi
Klebsiella pneumoniae testing: Professor Jian li and Heidi Yu at Monash institute of pharmaceutical research
Radiation protection therapeutic: Professor Tom Karagiannis and Dr. Natalie Bonvino
Each therapeutic was listed under one of the categories (1-4) below.
These include therapeutics designed for the treatment against :
Influenza
Rhinovirus (common cold)
Klebsiella pneumoniae
Cellular radiation protection
Each of the formulae are designed to be used for treatment in a human being who is suffering from one of these conditions.
Basic research outcomes /conclusions: Outcomes of particular experiments are shown as
raw data.
These summaries of the data (results) led to basic research conclusions which were based on the relevant researcher’s interpretation of the data.
The Researcher at Swinburne who tested the Influenza therapeutic in vitro concluded, “at all tested levels the therapeutic showed minimal toxicity against cells and performed even better than the current Anti- flu drugs".
According to the researcher at Melbourne institute of medical research - phi, and regarding the Rhinovirus (common cold) therapeutic, ”it inhibited the Rhinovirus, including viral RNA levels. Further testing on the mechanism behind the rhinovirus inhibition suggested that the therapeutic was suppressing genes P56, MxA, OAS, ISG15. The cold therapeutic also had low cytotoxicity up to 1000 ug”.
Concerning the Klebsiella Pneumoniae therapeutic, ”it showed inhibition of one strain (a polymyxin susceptible strain but not against a polymyxin resistant strain“. This preliminary study was done at Monash institute of pharmaceutical research.
The radiation protection therapeutic was designed to protect individuals who could be exposed to high levels of ionizing radiation (i.e gamma rays) following nuclear disasters, nuclear industry workers who may be exposed to ongoing radiation, people undergoing radiation therapy (e.g. for cancer therapy). The therapeutic is designed to reduce the negative effects of the ionizing radiation on the cells DNA and thus to reduce the incidence of, for example, cancer caused by this high energy radiation. This study was carried out at Baker-IDI. Concerning the radiation protection formula, “the formulation did protect from radiation induced damage (DNA double strand breaks) in normal rat heart cells by about 50%. The formulation itself was not toxic to heart cells“.
Please peruse the data by clicking the button at the end of this article. I hope it might be of some interest and help to you.
Special thanks to each of the researcher’s who were forward thinking enough and kind enough to take a preliminary look at each of these herbal therapeutics.